Susan E. Graf - Jun 11, 2025 Form 4 Insider Report for Aardvark Therapeutics, Inc. (AARD)

Role
Director
Signature
/s/ Nelson Sun, as Attorney-in-Fact
Stock symbol
AARD
Transactions as of
Jun 11, 2025
Transactions value $
$0
Form type
4
Date filed
6/13/2025, 04:05 PM
Previous filing
Jun 6, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Graf Susan E Director C/O AARDVARK THERAPEUTICS, INC., 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO /s/ Nelson Sun, as Attorney-in-Fact 2025-06-13 0001577637

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AARD Stock Option (right to buy) Award $0 +30.5K $0.00 30.5K Jun 11, 2025 Common Stock 30.5K $11.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in full on June 11, 2026, subject to the Reporting Person's continuous service through the vesting date, inclusive.